drugset / Trial / NCT00364559

Effect of Rosuvastatin in Intracerebral Hemorrhage

NCT00364559

Phase 2 Completed 75 enrolled Autonomous University of San Luis Potosí
Non-randomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether rosuvastatin is effective in the management of acute phase of intracerebral hemorrhage and if it impact outcome by NIHSS.

Timeline

Start
2006-08
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 20 mg